MrMichael Connolly

Clinical Lecturer

Pharmacy

  • Clinical Lecturer
    Pharmacy

FUNDED PROJECTS

  • GRANT
    Preventing Adverse Drug Reactions in the Elderly
    1 Jan 2019 - 30 Jun 2023
    People funded by this grant:
    • Bereznicki L,
    • Curtain C,
    • Bereznicki B,
    • Cousins J,
    • Connolly M
    Project Total: $274,000; Based on our prospective adverse drug reaction (ADR) registry:1 * 15% of medical admissions to Tasmanian public hospitals in elderly patients were ADR-related, * 89% were preventable, * 17% patients had a repeat ADR within 12 months, and * One third of patients with repeat ADRs experienced the same ADR caused by the same medications. From this clinical registry, we developed and validated an ADR risk prediction score (PADR-EC).2 We hypothesise that ADR risk stratification during hospitalisation and communication of this risk, together with recommendations that target the specific risk factors identified, to GPs at discharge will reduce the risk of ADR-related hospitalisation. Design: A randomised controlled trial (RCT) at the Royal Hobart Hospital, the major public hospital in Tasmania. Population: Over 12-months, 1000 patients ≥65 years with unplanned admissions to medical wards will be recruited and randomly allocated to intervention or control groups. Intervention: A researcher will perform an ADR risk assessment using the PADR-EC Score,2 which is the sum of points assigned to 5 independent predictors of ADR-related hospitalisation. Based on the PADR-EC Score and the specific risk factors identified, recommendations to reduce the risk of ADRs will be determined. Recommendations will relate to: * post-discharge medication management services, * monitoring of specific parameters/medications, and * de-prescribing strategies. The PADR-EC Score and recommendations will be communicated to the patient and clinical team during hospitalisation, and the patient's GP, alongside the usual information, in the electronic discharge summary. Control: Usual hospital care, with GPs receiving the standard discharge summary. Follow up: All participants will be followed by the research team for 12-months to identify ADRs (including their management and outcome) and health services received. Outcomes: ADR-related hospitalisation (primary); ADRs requiring hospital treatment, change in therapy or specific treatment (secondary). The study will be powered to detect a 5% difference in the primary outcome Funded by: Hospitals Contribution Fund Research Foundation - HCF - Grant-Health Services Research Program ($274,000); University of Tasmania.
  • UTAS INTERNAL FUNDING
    Improving clinical outcomes by increasing concordance with antibiotic guidelines for Community Acquired Pneumonia (CAP).
    13 Aug 2014 - 20 Jul 2016
    People funded by this grant:
    • Razi Zaidi T,
    • Anderson T,
    • Flanagan K,
    • Connolly M,
    • McKenzie D
    Project Total: $59,250; CAP leads to 60,000 hospital admissions in Australia annually and 3,000 deaths. Compliance with CAP guidelines is known to be low in Royal Hobart Hospital (RHH). UTAS and RHH have been developing guidelines, clinical pathways for emergency doctors and education for professionals about the pathway and the guidelines. Mortality rates at RHH have come down significantly since the UTAS and RHH work. Research will implement the RHH known strategy into the other Tasmanian Health Organisations (THOs). Educational components will improve the knowledge of the clinical workforce re optimal use of antibiotics in the management of CAP. Funded by: University of Tasmania; University of Tasmania.
  • GRANT
    Improving clinical outcomes by increasing concordance with antibiotic guidelines for Community Acquired Pneumonia (CAP).
    University of Tasmania1 Feb 2014 - 30 Apr 2015
    People funded by this grant:
    • Razi Zaidi ST,
    • Anderson TL,
    • Flanagan K,
    • Connolly MJ,
    • McKenzie D
    Project Total: $59,250; CAP leads to 60,000 hospital admissions in Australia annually and 3,000 deaths. Compliance with CAP guidelines is known to be low in Royal Hobart Hospital (RHH). UTAS and RHH have been developing guidelines, clinical pathways for emergency doctors and education for professionals about the pathway and the guidelines. Mortality rates at RHH have come down significantly since the UTAS and RHH work. Research will implement the RHH known strategy into the other Tasmanian Health Organisations (THOs). Educational components will improve the knowledge of the clinical workforce re optimal use of antibiotics in the management of CAP. Funded by: University of Tasmania vTAHSP Demonstration Projects ($59,250)